OUTCOME OF INTERSTITIAL LUNG DISEASE (ILD) IN ANTI-PM/SCL PATIENTS WITH SYSTEMIC SCLEROSIS: RESULTS FROM AN EUSTAR CASE-CONTROL STUDY.

被引：0
|
作者：
Lazzaroni, M. G. [1 ]
Campochiaro, C. [2 ,3 ,4 ]
Marasco, E. [5 ]
De Vries-Bouwstra, J. [6 ]
Franceschini, F. [1 ]
Del Galdo, F. [7 ]
Denton, C. [3 ,4 ]
Cavagna, L. [5 ]
Distler, O. [8 ]
Allanore, Y. [9 ,10 ]
Airo, P. [1 ]
机构：
[1] Univ Brescia, ASST Spedali Civili Brescia, Brescia, Italy
[2] Ist Sci San Raffaele, Milan, Italy
[3] Royal Free Hosp, London, England
[4] UCL, Med Sch, London, England
[5] Univ Pavia, Hosp IRCCS Policlin S Matteo Fdn Pavia, Pavia, Italy
[6] Leiden Univ Med Ctr LUMC, Leiden, Netherlands
[7] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[8] Univ Hosp Zurich, Zurich, Switzerland
[9] Univ Paris 05, Paris, France
[10] Cochin Hosp, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.4890
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0328
引用
收藏
页码：1105 / 1106
页数：2
相关论文
共 50 条
  • [41] Anti-Ro/SSA antibodies are predictive of more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database
    Blaz, Burja
    Marouane, Boubaya
    Cosimo, Bruni
    Patricia, Carreira E.
    Christina, Bergmann
    Lidia, Ananyeva P.
    Gabriela, Riemerkasten
    Okada, Masado
    De, Vries-Bouwstra Jeska
    Edoardo, Rosato
    Marie-Elise, Truchetet
    Nicoletta, Del Papa
    Antonella, Marcoccia
    Fabiola, Atzeni
    Tim, Schmeiser
    Madelon, Vonk
    Francesco, Del Galdo
    Oliver, Distler
    Muriel, Elhai
    SWISS MEDICAL WEEKLY, 2024, 154 : 3S - 3S
  • [42] Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) and Organ Damage: Data from the SENSCIS Trial
    Pope, Janet
    Proudman, Susanna
    Stevens, Wendy
    Henes, Joerg
    Simonovska, Rozeta
    Alves, Margarida
    Allanore, Yannick
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3025 - 3027
  • [43] OPEN LABELED STUDY OF IMATINIB MESYLATE (GLEEVEC) IN THE TREATMENT OF SYSTEMIC SCLEROSIS- ASSOCIATED ACTIVE INTERSTITIAL LUNG DISEASE (SSC-ILD): PRELIMINARY RESULTS
    Khanna, D.
    Saggar, R.
    Mayes, M.
    Marnian, P.
    Clements, P.
    Furst, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S75 - S75
  • [44] THE ASSOCIATION OF AUGMENTATION MAMMAPALSTY WITH SYSTEMIC-SCLEROSIS - PRELIMINARY-RESULTS FROM A CASE-CONTROL STUDY
    HOCHBERG, MC
    WHITE, B
    MEDSGER, TA
    WEISMAN, M
    WIGLEY, FM
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S71 - S71
  • [45] Open Labeled Study of Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis-Associated Active Interstitial Lung Disease (SSc-ILD): Preliminary Results
    Saggar, R.
    Khanna, D.
    Mayes, M. D.
    Clements, P.
    Maranian, P.
    Furst, D. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [46] Effect of nintedanib in patients with limited and extensive systemic sclerosis-associated interstitial lung disease (SSc-ILD): data from the SENSCIS trial
    Wiewrodt, R.
    Goh, N.
    Denton, C. P.
    Lynch, D. A.
    Maher, T. M.
    Smith, V
    Prasse, A.
    Cottin, V
    Spiera, R.
    Stock, C.
    Gahlemann, M.
    Alves, M.
    Wells, A. U.
    PNEUMOLOGIE, 2021, 75 : S29 - S30
  • [47] Effect of Nintedanib in Patients with Limited and Extensive Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Data from the SENSCIS Trial
    Goh, N.
    Denton, C. P.
    Lynch, D. A.
    Maher, T. M.
    Smith, V.
    Prasse, A.
    Cottin, V.
    Spiera, R.
    Stock, C.
    Gahlemann, M.
    Alves, M.
    Wells, A. U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [48] Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case-Control Study
    Esposito, Anthony J.
    Menon, Aravind A.
    Ghosh, Auyon J.
    Putman, Rachel K.
    Fredenburgh, Laura E.
    El-Chemaly, Souheil Y.
    Goldberg, Hilary J.
    Baron, Rebecca M.
    Hunninghake, Gary M.
    Doyle, Tracy J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (12) : 1710 - 1713
  • [49] Risk of drug-induced interstitial lung disease in hospitalised patients: a nested case-control study
    Jo, Taisuke
    Michihata, Nobuaki
    Yamana, Hayato
    Morita, Kojiro
    Ishimaru, Miho
    Yamauchi, Yasuhiro
    Hasegawa, Wakae
    Urushiyama, Hirokazu
    Uda, Kazuaki
    Matsui, Hiroki
    Fushimi, Kiyohide
    Yasunaga, Hideo
    Nagase, Takahide
    THORAX, 2021, 76 (12) : 1193 - 1199
  • [50] CONTINUED TREATMENT WITH NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD): THREEYEAR DATA FROM SENSCIS-ON
    Allanore, Y.
    Vonk, M.
    Distler, O.
    Azuma, A.
    Mayes, M.
    James, A.
    Kohlbrenner, V.
    Alves, M.
    Khanna, D.
    Highland, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 281 - 281
12345